Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Conference Papers
, 2014, 'P427 POTENTIAL IMPACT OF IMPROVED TREATMENT ON DISEASE BURDEN OF CHRONIC HEPATITIS C IN AUSTRALIA', in Journal of Hepatology, Elsevier, ENGLAND, London, pp. s210, presented at 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, ENGLAND, London, 09 April 2014 - 13 April 2014, http://dx.doi.org/10.1016/s0168-8278(14)60589-4
, 2013, 'Impaired T cell glucose metabolism during chronic hepatitis C virus infection', in Narci T (ed.), Journal of Gastroenterology and Hepatology, Wiley Online, Melbourne, Australia, pp. 171 - 171, presented at Australian Gastroenterology Week 2013, Melbourne, Australia, 07 October 2013 - 09 October 2013, http://dx.doi.org/10.1111/jgh.12365_14
, 2013, 'Hepatitis C patients with hepatocellular carcinoma undergoing transarterial chemoembolisation', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 64 - 64
, 2012, 'Hepatocellular Carcinoma Risk In Chronic Hepatitis B Patients Achieving Viral Suppression With Antiviral Therapy', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 354A - 354A, presented at 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 09 November 2012 - 13 November 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310955601331&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2012, 'IMPAIRED T-CELL GLUCOSE METABOLISM DURING CHRONIC HEPATITIS C VIRUS INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, pp. S302 - S302, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), SPAIN, Barcelona, 18 April 2012 - 22 April 2012, http://dx.doi.org/10.1016/S0168-8278(12)60782-X
, 2012, 'T CELLS CO-EXPRESSING CCR2, CCR5, CXCR3, AND CXCR6 ARE PREFERENTIALLY ENRICHED IN THE HCV-INFECTED LIVER', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, pp. S313 - S313, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), SPAIN, Barcelona, 18 April 2012 - 22 April 2012, http://dx.doi.org/10.1016/S0168-8278(12)60813-7
, 2012, '812 HEPATITIS C VIRUS-SPECIFIC EFFECTOR AND REGULATORY CD4+ T CELLS IN PRIMARY INFECTION RESULTING IN CLEARANCE OR CHRONIC INFECTION', in Journal of Hepatology, Elsevier, pp. s317, http://dx.doi.org/10.1016/s0168-8278(12)60824-1
, 2010, 'HEPATIC MICRORNA 135A*REGULATES HEPATIC TRIGLYCERIDE STORAGE AND IS REPRESSED DURING HCV INFECTION', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 727A - 727A, presented at 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 29 October 2010 - 02 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000288775601163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2010, 'SERUM PROTEOMIC PROFILES ASSOCIATED WITH IL28B GENOTYPE AMONG CHC PATIENTS', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 727A - 728A, presented at 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 29 October 2010 - 02 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000288775601164&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2009, 'HEPATIC MICRORNAS EXPRESSION IN OBESE SUBJECTS WITH CHRONIC HCV', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 940A - 940A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 30 October 2009 - 03 November 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456001376&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2009, 'RELATIONSHIP OF RETINOL BINDING PROTEIN-4 WITH LIVER INJURY IN MORBIDLY OBESE SUBJECTS', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 789A - 789A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 30 October 2009 - 03 November 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456001030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2009, 'STATINS AND LIVER INJURY IN MORBIDLY OBESE SUBJECTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 789A - 789A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 30 October 2009 - 03 November 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456001029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2009, 'THE MICRORNA MIR-923 IS HIGHLY ABUNDANT AND DIFFERENTIALLY EXPRESSED BETWEEN NORMAL AND FATTY LIVERS', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 1185A - 1185A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 30 October 2009 - 03 November 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456001904&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2009, 'Percutaneous liver biopsy by prior ultrasound marking versus direct ultrasound guidance: complications and adequacy', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A294 - A295
, 2008, 'EFFECT OF OBESITY ON INTERFERON STIMULATED GENES EXPRESSION IN CHRONIC HCV INFECTION', in HEPATOLOGY, JOHN WILEY & SONS INC, CA, San Francisco, pp. 864A - 865A, presented at 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, CA, San Francisco, 31 October 2008 - 04 November 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259757401628&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2008, 'EFFECT OF STEATOSIS ON THE INTRAHEPATIC CYTOKINE/CHEMOKINE RESPONSES IN CHRONIC HCV', in HEPATOLOGY, JOHN WILEY & SONS INC, CA, San Francisco, pp. 789A - 789A, presented at 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, CA, San Francisco, 31 October 2008 - 04 November 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259757401463&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2008, 'Preparedness for candidate hepatitis C vaccine trials in people who inject drugs: challenges and opportunities', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A358 - A358, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264953600072&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2008, 'The insulin resistance of chronic hepatitis C is peripheral and not hepatic', in DIABETES, AMER DIABETES ASSOC, CA, San Francicso, pp. A20 - A21, presented at 67th Annual Meeting of the American-Diabetes-Association, CA, San Francicso, 06 June 2008 - 10 June 2008
, 2008, 'Clinical characteristics of patients with hepatocellular carcinoma presenting to a single tertiary institute', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A279 - A279, presented at Journal of Gastroenterology and Hepatology
, 2008, 'Differential expression of interferon stimulating genes in obese subjects receiving treatment for chronic hepatitis C', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A282 - A282, presented at Journal of Gastroenterology and Hepatology
, 2008, 'EFFECT OF OBESITY ON INTERFERON STIMULATED GENES EXPRESSION IN CHRONIC HCV INFECTION', in Hepatology, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. 1248 - 1249, presented at Hepatology
, 2008, 'Effect of obesity on the intrahepatic cytokine/chemokine responses in chronic hepatitis C', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A285 - A285, presented at Journal of Gastroenterology and Hepatology
, 2008, 'EFFECT OF STEATOSIS ON THE INTRAHEPATIC CYTOKINE/CHEMOKINE RESPONSES IN CHRONIC HCV', in Hepatology, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. 1080 - 1081, presented at Hepatology
, 2008, 'High retinol binding protein-4 and low adiponectin levels are associated with steatosis in bariatric patients', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A285 - A285, presented at Journal of Gastroenterology and Hepatology
, 2008, 'Statins may aggravate liver injury in obese subjects with nonalcoholic fatty liver disease', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A283 - A283, presented at Journal of Gastroenterology and Hepatology
, 2008, '527 AUTOLOGOUS ADULT HAEMATOPOIETIC STEM CELL TRANSPLANTATION', in Journal of Hepatology, Elsevier, pp. s198, http://dx.doi.org/10.1016/s0168-8278(08)60529-2
, 2007, 'Polymorphisms in adrenergic receptors, adiponcetin and adiponectin receptors influence fibrosis rates and response to therapy in chronic HCV', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 440A - 440A, presented at 58th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 02 November 2007 - 06 November 2007, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249910400460&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2007, 'A pilot study to assess the impact of rosuvastatin therapy on HCV RNA and lipid fractions in chronic hepatitis c patients', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. A741 - A741, presented at Digestive Disease Week Meeting/108th Annual Meeting of the American-Gastroenterological-Association, DC, Washington, 19 May 2007 - 24 May 2007
, 2005, 'Microarray analysis of peripheral blood mononuclear cell (PBMC) messenger RNA in treated patients with chronic HCV infection', in GASTROENTEROLOGY, W B SAUNDERS CO, IL, Chicago, pp. A749 - A749, presented at Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week, IL, Chicago, 14 May 2005 - 19 May 2005
, 2005, 'A serum proteomic analysis in hepatitis C fibrosis', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. 117 - 117, presented at 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, FRANCE, Paris, 13 April 2005 - 17 April 2005
, 2005, 'Does ribavirin therapy select resistance mutations in HCV polymerase?', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. 226 - 226, presented at 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, FRANCE, Paris, 13 April 2005 - 17 April 2005
, 2004, 'Independent evaluation of a serum biochemical marker panel (Fibrotest) to predict fibrosis in a US cohort of chronic HCV patients.', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 686A - 686A, presented at 55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 29 October 2004 - 02 November 2004
, 2003, 'Microarray analysis of intrahepatic gene expression in different patterns of HCV recurrence post liver transplant.', in HEPATOLOGY, W B SAUNDERS CO, MASSACHUSETTS, BOSTON, pp. 171A - 171A, presented at 54th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, MASSACHUSETTS, BOSTON, 24 October 2003 - 28 October 2003
, 2003, 'Differential gene expression patterns in acute rejection associated with HCV recurrence post liver transplant', in LIVER TRANSPLANTATION, W B SAUNDERS CO, SPAIN, BARCELONA, pp. C36 - C36, presented at 9th Meeting of the International-Liver-Transplantation-Society/13th Meeting of the Liver-Intensive-Care-Group-of-Europe, SPAIN, BARCELONA, 18 June 2003 - 21 June 2003
, 2001, 'Predictors of long term outcome following liver transplantation for HCV cirrhosis in a population with significant genotype 3 and 4 infection.', in HEPATOLOGY, W B SAUNDERS CO, pp. 407A - 407A
, 2000, 'Intrahepatic cytokine expression in cholestatic versus non-cholestatic recurrant hepatitis C virus (HCV) infection post liver transplantation.', in HEPATOLOGY, WILEY-BLACKWELL, pp. 217A - 217A
Conference Posters
, 2014, 'Factors associated with medication adherence in patients living with cirrhosis', Boston, presented at American Association Society for Liver Disease (AASLD) Liver meeting, Boston, 07 November 2014 - 10 November 2014
Conference Abstracts
, 2026, 'Service Mapping and Integration for Liver Health: Addressing Gaps in Hepatitis-related Care Across New South Wales, Australia', in International Journal of Integrated Care, Ubiquity Press, Vol. 26, pp. 357, http://dx.doi.org/10.5334/ijic.icic25357
, 2022, 'MONITORING QUALITY OF CARE IN HEPATOCELLULAR CARCINOMA: A MODIFIED DELPHI CONSENSUS', in HEPATOLOGY, WILEY, Vol. 76, pp. S1311 - S1312, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000870796604144&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'Effect of gut influence on the immune environment in preclinical hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 37, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852585700071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'IDDF2022-ABS-0052 Effect of gut influence on the immune environment in pre-clinical HCC', BMJ, pp. a5.1 - a5a5, presented at Gut – IDDF Young Investigator Award, http://dx.doi.org/10.1136/gutjnl-2022-iddf.6
, 2020, 'Defining the temporal evolution of the gut microbiome and associated intrahepatic immune response in the Mdr2-/- model of hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 19 - 19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2020, 'Impact of the gut microbiome and metabolome on the peripheral immune response in non-alcoholic fatty liver disease-related hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 19 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Alterations in metabolic risk factor profile in the transition from non-alcoholic fatty liver disease (NAFLD) to NAFLD-related hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 58 - 58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Outcomes based on plasma biomarkers for the Phase III CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 41 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Virtual clinic for positive fecal occult blood test result: Our local experience', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 238 - 238, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100377&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Factors associated with adherence to hepatocellular carcinoma surveillance in patients undergoing hepatitis B anti-viral therapy in Australia.', in HEPATOLOGY, WILEY, MA, Boston, Vol. 64, pp. 811A - 811A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493804001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Predictors of non-adherence to HBV anti-viral therapy', in HEPATOLOGY, WILEY, MA, Boston, Vol. 64, pp. 812A - 812A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493804004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2000, 'Hepatitis C Virus prevalence and genotype among Australian injecting drug users in the 1970s.', in HEPATOLOGY, W B SAUNDERS CO, Vol. 32, pp. 279A - 279A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089622400468&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1999, 'Abstracts of papers accepted for presentation at the 17th International Symposium on Gastrointestinal Motility', in Neurogastroenterology & Motility, Vol. 11, pp. 247 - 303, http://dx.doi.org/10.1111/j.1365-2982.1999.tb00001.x